Podcast

Jim Kelly: Never Give Up

Author(s):

Kristie L. Kahl

In this special edition of CURE Talks Cancer, we spoke with NFL Hall of Fame quarterback Jim Kelly about his experience with head and neck cancer, and the humbling experience of winning the Jimmy V award for Perseverance at this year’s ESPY Awards.

Jim Kelly is a decorated NFL Hall of Fame quarterback who led the Buffalo Bills to four consecutive Super Bowl appearances and six divisional championships from 1988 to 1995.

In 2013, Jim was diagnosed with squamous cell carcinoma in his upper jaw and has since experienced two recurrences. While looking to the four Fs (faith, family, friends and the fans) to help him through his cancer journey, Jim lives by making the difference today for someone who is fighting for their tomorrow. It is because of this, Jim was honored with the Jimmy V Award for Perseverance at this year’s ESPY Awards.

In this special edition of CURE Talks Cancer, we spoke with Jim about his experience with head and neck cancer, and the humbling experience of winning the Jimmy V award.

Related Videos
Image of man with black hair.
Image of a man with short hair, wearing a buttoned-up shirt.
Dr. Michael Moore
Dr. Michael Moore
Dr. Michael Moore
Dr. Michael Moore
Related Content
Two illustrations of people with tumors in the throat and jaw area.
October 19th 2024

Similar Survival Shown With Radiation Versus Robotic Surgery in HNC

Ashley Chan
Patients with a head and neck cancer subtype did not show differences in survival outcomes when treated with radiation versus transoral robotic surgery.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.
October 15th 2024

Keytruda Regimen May Improve Event-Free Survival in Head and Neck Squamous Cell Carcinoma

Darlene Dobkowski, MA
A Keytruda-based regimen given both before and after surgery for patients with head and neck squamous cell carcinoma may improve event-free survival.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of a vial of treatment and a syringe with "out of stock," signifying the chemo shortage.
September 30th 2024

Chemo Shortage Increases Treatment Costs by 16% for Head and Neck Cancer

Darlene Dobkowski, MA
In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the cisplatin shortage.
head and neck cancer
September 5th 2024

Cancer Vaccine UV1 Shows No Survival Benefit in Head and Neck Cancer

Alex Biese
A trial showed no overall survival or progression-free survival benefit from the addition of UV1 to Keytruda in patients with HNSCC.